Skip to main content
    ChemVerify
    Chemical Properties

    Peptide Sequence Notation: One-Letter Codes, Three-Letter Codes, and Modifications

    Complete guide to peptide sequence notation systems — IUPAC one-letter and three-letter amino acid codes, N-terminal and C-terminal modifications, non-standard amino acids, and reading sequences on Certificates of Analysis.

    ChemVerify Research Team
    12 min read
    Published March 20, 2026
    Peptide Sequence Notation: One-Letter Codes, Three-Letter Codes, and Modifications — featured illustration

    For laboratory research use only. Not for human consumption.

    TL;DR: Peptide sequences are written N-terminus to C-terminus using one-letter codes (compact, for alignments), three-letter codes (unambiguous, for synthesis), or full IUPAC nomenclature. Post-translational modifications, non-natural amino acids, and terminal modifications require specific notation conventions. Mastering these systems is essential for accurate communication in peptide ordering, literature interpretation, and database searches.

    Last verified: March 2026 | Data accuracy confirmed by ChemVerify Editorial Team

    Notation Systems Overview

    Peptide sequences are written from the N-terminus (amino end, left) to the C-terminus (carboxyl end, right), following IUPAC-IUB conventions established in 1983. Two parallel notation systems are in standard use: the one-letter code (compact, used for long sequences and databases) and the three-letter code (more readable, used for shorter sequences and when modifications must be indicated clearly).

    The choice between systems is largely contextual. Research databases (UniProt, PDB) use one-letter codes. Certificates of Analysis and peptide vendor catalogs typically use three-letter codes for clarity, especially when non-standard amino acids or modifications are present.

    The 20 Standard Amino Acids

    The 20 genetically encoded L-amino acids each have an unambiguous one-letter and three-letter designation:

    • A = Ala (Alanine)
    • C = Cys (Cysteine)
    • D = Asp (Aspartic acid)
    • E = Glu (Glutamic acid)
    • F = Phe (Phenylalanine)
    • G = Gly (Glycine)
    • H = His (Histidine)
    • I = Ile (Isoleucine)
    • K = Lys (Lysine)
    • L = Leu (Leucine)
    • M = Met (Methionine)
    • N = Asn (Asparagine)
    • P = Pro (Proline)
    • Q = Gln (Glutamine)
    • R = Arg (Arginine)
    • S = Ser (Serine)
    • T = Thr (Threonine)
    • V = Val (Valine)
    • W = Trp (Tryptophan)
    • Y = Tyr (Tyrosine)

    Ambiguity Codes

    • B = Asx (Asparagine or Aspartic acid — ambiguous)
    • Z = Glx (Glutamine or Glutamic acid — ambiguous)
    • J = Xle (Leucine or Isoleucine — ambiguous, used in MS sequencing where isobaric residues cannot be distinguished)
    • X = Xaa (Any amino acid or unknown residue)
    • U = Sec (Selenocysteine — the 21st amino acid)
    • O = Pyl (Pyrrolysine — the 22nd amino acid)

    Terminal Modifications

    N-Terminal Modifications

    • H- (free amine): The default, unmodified N-terminus. Often omitted in notation: H-ACDEFG-OH is equivalent to ACDEFG-OH.
    • Ac- (acetyl): Acetylation of the N-terminal amine. Adds +42.04 Da. Written as Ac-SEQUENCE-OH. Blocks the positive charge and increases metabolic stability.
    • Fmoc- (fluorenylmethyloxycarbonyl): Synthesis protecting group. Should NOT be present on a finished peptide — its presence indicates incomplete deprotection.
    • pGlu- or pE- (pyroglutamate): Cyclized glutamic acid or glutamine at the N-terminus. Occurs naturally and may form spontaneously from N-terminal Gln.
    • Biotin- : Biotinylation for streptavidin binding applications. Adds +226.29 Da.
    • FITC- or FAM-: Fluorescent labels (fluorescein isothiocyanate or carboxyfluorescein).

    C-Terminal Modifications

    • -OH (free acid): The default, unmodified C-terminus with a free carboxyl group. Standard for most synthetic peptides.
    • -NH₂ (amide): Amidation of the C-terminal carboxyl. Removes the negative charge, increases stability, and is common in naturally occurring bioactive peptides. Mass difference: −1.00 Da compared to the free acid form.
    • -OMe (methyl ester): Methylation of the C-terminal carboxyl. Rare in research peptides.
    • The C-terminal modification significantly affects the molecular weight and must be specified on the CoA.

    Non-Standard Amino Acids

    D-Amino Acids

    D-enantiomers of standard amino acids are denoted by lowercase letters in one-letter code (e.g., a = D-Ala, f = D-Phe) or by the prefix D- or (D) in three-letter code (e.g., D-Ala, (D)Phe). D-amino acids increase resistance to proteolytic degradation and are commonly used in synthetic peptide design.

    Common Non-Standard Residues

    • Aib = α-aminoisobutyric acid (α-methylalanine) — helix stabilizer
    • Orn = Ornithine — Arg analog without guanidinium, +1 charge at physiological pH
    • Nle = Norleucine — Met isostere, resistant to oxidation
    • Cit = Citrulline — Arg analog without charge
    • Sar = Sarcosine (N-methylglycine) — N-methylated Gly
    • β-Ala = β-alanine — spacer residue with extended backbone
    • GABA = γ-aminobutyric acid — spacer with even longer backbone
    • Dab = 2,4-diaminobutyric acid — shorter Lys analog
    • Dap = 2,3-diaminopropionic acid — shortest diamine residue
    • Hyp = Hydroxyproline — hydroxylated Pro, found in collagen

    Post-Translational and Chemical Modifications

    Modifications are indicated in parentheses after the affected residue or as prefixes/suffixes:

    • Phosphorylation: pS, pT, pY or S(PO₃H₂), T(PO₃H₂), Y(PO₃H₂) — adds +79.97 Da
    • Methylation: K(Me), K(Me₂), K(Me₃) — mono/di/trimethylation of Lys
    • Acetylation (side chain): K(Ac) — acetylation of Lys ε-amine
    • PEGylation: K(PEG₂₀₀₀) — attachment of polyethylene glycol chain
    • Cyclization: Cyclo(sequence) — head-to-tail cyclization
    • Disulfide: Cys₁-Cys₅ or indicated by connectivity notation
    • Stapling: S₅ or R₈ — hydrocarbon-stapled residues for helix stabilization
    • Fatty acid conjugation: Palm-K or Myr-K — palmitoylation or myristoylation

    Reading Sequences on a CoA

    Example CoA Sequence

    A CoA might list: Ac-Gly-His-Lys-D-Phe-Ala-Glu-NH₂. This notation tells us:

    • Ac- → N-terminus is acetylated
    • Gly-His-Lys-D-Phe-Ala-Glu → six residues, with the fourth being D-phenylalanine (non-natural enantiomer)
    • -NH₂ → C-terminus is amidated
    • Expected MW calculation: sum all residue masses + Ac (+42.04) − H₂O (−18.02, peptide bond water loss per bond) + NH₂ amide adjustment (−0.98 vs free acid)

    Verification Steps

    • Count the residues and verify against the stated sequence length
    • Identify any non-standard residues or modifications and confirm their mass contributions
    • Calculate the expected molecular weight independently and compare to the CoA value
    • Check that terminal modifications are correctly reflected in the stated MW
    • Verify that disulfide bonds (if any) are accounted for in the mass (−2.016 Da per bond)
    • Confirm the sequence notation is internally consistent — the same sequence should produce the same MW regardless of whether one-letter or three-letter code is used

    Frequently Asked Questions

    What is the difference between one-letter and three-letter amino acid codes?

    One-letter codes (e.g., A for alanine, G for glycine) are compact and used in sequence alignments, database entries, and bioinformatics tools. Three-letter codes (e.g., Ala, Gly) are more readable and are standard in synthesis orders, chemical literature, and when specifying modifications. Both follow N→C terminal direction.

    How are D-amino acids indicated in peptide notation?

    D-amino acids are denoted with a lowercase 'd' prefix in three-letter notation (e.g., d-Ala, d-Phe) or with a lowercase letter in certain one-letter conventions. In some systems, D-amino acids use italic 'D-' prefix. Always verify the convention used by your supplier or publication.

    How do I notate N-terminal and C-terminal modifications?

    N-terminal modifications are written before the first residue (e.g., Ac-Ala for N-acetylation, FITC-Gly for fluorescein labeling). C-terminal modifications follow the last residue (e.g., Ala-NH2 for amidation). These modifications are critical for peptide stability and should always be explicitly specified in orders.

    What notation is used for cyclic peptides?

    Cyclic peptides are indicated by 'cyclo()' wrapping the sequence (e.g., cyclo(Arg-Gly-Asp-d-Phe-Lys)). Side-chain-to-side-chain cyclizations specify the linkage type and residue positions. Disulfide-cyclized peptides show the Cys residues with a connecting notation (e.g., Cys¹-Cys⁶).

    How are non-natural amino acids represented?

    Non-natural amino acids use systematic three-letter abbreviations in brackets or parentheses within the sequence (e.g., Aib for α-aminoisobutyric acid, Nle for norleucine, β-Ala for beta-alanine). PEG spacers and other non-amino acid linkers are written as chemical names or abbreviations (e.g., Ahx for aminohexanoic acid).

    Further Reading on ChemVerify

    • Read more: Peptide Aggregation: Why Peptides Clump and How to Prevent It → https://www.chemverify.com/learn/peptide-aggregation-clumping-prevention
    • Read more: Peptide Degradation: Deamidation, Oxidation, and How to Prevent It → https://www.chemverify.com/learn/peptide-degradation-deamidation-oxidation-prevention
    • Read more: Amino Acid Reference Table: Properties, Structures, and Classification → https://www.chemverify.com/learn/amino-acid-reference-table
    • Read more: Peptide Modifications: PEGylation, Lipidation, Cyclization, and D-Amino Acids → https://www.chemverify.com/learn/peptide-modifications-pegylation-lipidation-cyclization

    Compare Verified Vendors

    Browse COA-verified suppliers with exclusive discount codes and transparent pricing.

    Continue Reading

    Related Content